SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-240338
Filing Date
2018-08-07
Accepted
2018-08-07 07:05:35
Documents
6
Period of Report
2018-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d583407d8k.htm 8-K 17922
2 EX-99.1 d583407dex991.htm EX-99.1 90568
3 EX-99.2 d583407dex992.htm EX-99.2 1651
4 GRAPHIC g5834071a.jpg GRAPHIC 14729
5 GRAPHIC g5834072b.jpg GRAPHIC 23616
6 GRAPHIC g583407ex99_2s1g1.jpg GRAPHIC 418635
  Complete submission text file 0001193125-18-240338.txt   741082
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36329 | Film No.: 18996254
SIC: 2834 Pharmaceutical Preparations